Skip to main content
Livermore
Livermore
ZHEN

Chescapmanager LLC

SEC CIK
0001697162
Latest filing
Aug 14, 2026

KROS holding history

Keros Therapeutics, Inc. in every 13F filed by Chescapmanager LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KROS overviewAll 13F holders of KROSFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q2 2021
Holdings of KROS by Chescapmanager LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−10,105−100.0%Sold outHolders
Q4 202310,105$401.8K0.1%00.0%UnchangedHolders
Q3 202310,105$322.1K0.1%00.0%UnchangedHolders
Q2 202310,105$406.0K0.1%00.0%UnchangedHolders
Q1 202310,105$431.0K0.1%00.0%UnchangedHolders
Q4 202210,105$485.0K0.1%00.0%UnchangedHolders
Q3 202210,105$380.0K0.1%00.0%UnchangedHolders
Q2 202210,105$279.0K0.1%00.0%UnchangedHolders
Q1 202210,105$550.0K0.1%00.0%UnchangedHolders
Q4 202110,105$591.0K0.1%00.0%UnchangedHolders
Q3 202110,105$400.0K0.1%00.0%UnchangedHolders
Q2 202110,105$429.0K0.1%+10,105NewHolders